Latest Articles

Publication Date
All News Scientific
More evidence links physical activity with improved cancer survival - MSN

More evidence links physical activity with improved cancer survival MSN

Published: May 28, 2025, 12:20 a.m.
Read Full Article
More Evidence Links Physical Activity With Improved Cancer Survival, New ACS Study Finds - American Cancer Society Press Room

More Evidence Links Physical Activity With Improved Cancer Survival, New ACS Study Finds American Cancer Society Press Room

Published: May 21, 2025, 3:01 p.m.
Read Full Article
More Evidence Links Physical Activity With Improved Cancer Survival, New ACS Study Finds | Newswise - Newswise

More Evidence Links Physical Activity With Improved Cancer Survival, New ACS Study Finds | Newswise Newswise

Published: May 20, 2025, 11:30 p.m.
Read Full Article
and poor overall patient survival in - ResearchGate

and poor overall patient survival in ResearchGate

Published: May 11, 2025, 2:51 a.m.
Read Full Article
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer - Nature

DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer Nature

Published: May 10, 2025, 10:19 a.m.
Read Full Article
Uterine Cancer Survival Varies Widely by Race Across US - Medscape

Uterine Cancer Survival Varies Widely by Race Across US Medscape

Published: May 7, 2025, 12:27 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!